JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philippe Menasché
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kevelaitis, E.
Right arrow Articles by Menasché, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kevelaitis, E.
Right arrow Articles by Menasché, P.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2001;121:0155-0162
© 2001 The American Association for Thoracic Surgery


Cardiothoracic Transplantation

Ischemic preconditioning with opening of mitochondrial adenosine triphosphate–sensitive potassium channels or Na+/H+ exchange inhibition: Which is the best protective strategy for heart transplants?

Egidijus Kevelaitis, MD, PhDd, Abdeslam Oubénaissa, MD, PhDb, Christian Mouasb, Jacqueline Peynet, MDc, Philippe Menasché, MD, PhDa,b

From the Department of Cardiovascular Surgery, Hôpital Bichat,a INSERM U-127,b the Department of Biochemistry,c Hôpital Lariboisière, Paris, France, and the Department of Physiology, Kaunas University of Medicine, Kaunas, Lithuania.d

Received for publication March 23, 2000. Revisions requested May 15, 2000; revisions received Sept 1, 2000. Accepted for publication Sept 8, 2000. Address for reprints: Philippe Menasché, MD, PhD, Department of Cardiovascular Surgery, Hôpital Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18, France.

Objective: This study was designed to compare ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels and Na+/H+ exchange inhibition in an isolated heart model of cold storage, simulating the situation of cardiac allografts.
Methods: Sixty-seven isolated isovolumic buffer-perfused rat hearts were arrested with and stored in Celsior solution (Imtix-Sangstat) at 4°C for 4 hours before a 2-hour reperfusion. Group I hearts served as controls and were arrested with and stored in Celsior solution. In group II, hearts were preconditioned by two 5-minute episodes of global ischemia, each separated by 5 minutes of reperfusion before arrest with Celsior solution. Group III hearts were arrested with and stored in Celsior solution supplemented with 100 µmol/L of the mitochondrial adenosine triphosphate-sensitive potassium channel opener diazoxide. In group IV, hearts received an infusion of diazoxide (30 µmol/L) during the first 15 minutes of reperfusion. Group V hearts underwent a protocol combining both interventions used in groups III and IV. In group VI, hearts were arrested with and stored in Celsior solution supplemented with 1 µmol/L of the Na+/H+ exchange inhibitor cariporide. Group VII hearts received an infusion of cariporide (1 µmol/L) during the first 15 minutes of reperfusion. In group VIII, hearts underwent a protocol combining both interventions used in groups VI and VII. Group IX hearts were ischemically preconditioned as in group II, and sustained Na+/H+ exchange inhibition during both storage and early reperfusion was used as in group VIII.
Results: On the basis of comparisons of postischemic left ventricular contractility and diastolic function, coronary flow, total creatine kinase leakage, and myocardial water content, values indicative of improved protection were obtained by combining ischemic preconditioning with Na+/H+ exchange inhibition by cariporide given during storage and initial reperfusion. The endothelium-dependent vasodilatory postischemic responses to 5-hydroxytryptamine or acetylcholine and endothelium-independent responses to papaverine were not affected by these interventions.
Conclusions: These data suggest that cardioprotectionconferred by the Na+/H+ exchange inhibitor cariporide is additive to that of ischemic preconditioning and might effectively contribute to improve donor heart preservation during cardiac transplantation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The American Association for Thoracic Surgery.